Rising Focus on Remote Health Monitoring propelling Vocal Biomarker Demand: Fact. MR

The increasing research on the impact of hardening of arteries on speech production and demand for diagnosing mental health conditions using verbal pattern and sound vibrations have been creating ideal conditions for vocal biomarker market growth.

Fact.MR, Dublin: The vocal biomarker market is predicted to rise at 23.3% CAGR by the end of 2027. As per a study by Fact MR, identification and implementation of vocal biomarkers in the therapeutic diagnosis of mental health conditions, cardiovascular diseases, brain injury, and cognitive impairment is predicted to create favorable growth conditions among the market players. Psychiatric disorder is expected to be the key indicator, needing the applications of vocal biomarkers.

Successful clinical trials of Health Insurance Portability and Accountability Act (HIPAA) compliant vocal biomarkers will become a diagnostic alternative to expensive diagnostic techniques such as magnetic resonance imaging (MRI), computed tomography (CT) scan and X-ray.

Request Sample of the report on the vocal biomarkers market

https://www.factmr.com/connectus/sample?flag=S&rep_id=719

“The arrival of HIPAA compliant vocal biomarkers and collaboration of government agencies with voice based companies are predicted to globally expand vocal biomarkers market. Rising cases of stress and depression along with prevalence of diseases such as Parkinson’s diseases has fuelled the development of vocal biomarkers”, said a lead analyst at Fact.MR.

Vocal biomarkers market: Key Findings

  • Extensive research on vocal biomarkers by Beyond Verbal led to compilation of 2.5 Million voice samples in 40 different languages.
  • Demand from psychiatric disorder for vocal biomarkers will generate increasing sales
  • Worldwide sales of vocal biomarkers are envisioned to exceed around US $390 Mn.
  • Demand from hospitals & clinics poised to surge as the continue witnessing increasing footfall of patients
  • Increasing cases of respiratory disorders will continue fuelling demand for vocal biomarkers, emerging as a key segment in terms of indication

Explore 141 tables and 105 figures of the study. Request ToC of the report at

https://www.factmr.com/report/719/vocal-biomarker-market

Vocal biomarkers market – Key Driving Factors

  • Need for early detection of psychiatric and neurological disorders in developing countries and cost effective substitute for minimal invasive technologies have emerged as chief drivers
  • Integration of vocal biomarkers in defense and security agencies for lie detection and war trauma treatment will boost the demand in vocal biomarkers market
  • Increasing Prevalence of cardiovascular and respiratory diseases in developed countries industry is contributing towards increase in sales.

Vocal biomarkers market – Key Restraints

  • Lack of stability for Alzheimer’s and other chronic neurological diseases for long clinical trials restricts the sales.
  • Expensive vocal biomarker application techniques are stressing the healthcare economy, thus limiting the market expansion.

Vocal biomarkers market – Covid-19 Impact

COVID-19 pandemic disrupted the world healthcare economy. This positively affected the vocal biomarkers market. According to CDC, 30.9% people suffered from anxiety disorder. The use of verbal biomarkers in cloud based API engine integrated with virtual private assistant helped in treatment of psychological disorders remotely, thus enabling rapid the verbal biomarkers market growth. This growth is expected to increase due to increasing trend of self-diagnosis and requirement of social distancing assisting the verbal biomarkers market.

Competitive Landscape

Some of the leading verbal biomarker manufacturers are Beyond Verbal, Cogito Corporation, Audio Profiling, IBM Corporation and Sonde Health. Health-related applications, life sciences and healthcare organizations are collaborating with voice based technological companies for rapid development of reliable and accurate verbal biomarkers.

For instance, Sonde Health Inc., collaborated with Massachusetts Institute of Technology (MIT) for licensing the technology that enables diagnosing and monitoring various conditions and diseases using voice based platform.

Beyond Verbal developed a cloud based API engine to enhance the sensitivity of virtual private assistants and eliminating its blind spots enabling remote health monitoring. These collaborative strategies will boost the development of accurate verbal biomarkers and remote health monitoring using personalized technologies.

More Insights on the Vocal biomarkers market

In its latest report, Fact.MR offers unbiased analysis of the global verbal biomarkers market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of Technique (Frequency, Amplitude, Error rate, phonation time, vocal rise, voice tremor, pitch) and end user (CROs, hospitals and clinics, Academic and research centers) across six regions (North America, Latin America, Europe, Japan, Asia Pacific excluding Japan, and Middle East & Africa).

Request more information about Report Methodology

https://www.factmr.com/connectus/sample?flag=RM&rep_id=719

Explore Fact.MR’s Coverage on the Healthcare Domain

High Sensitivity Cardiac Biomarker Market: A recent study by Fact.MR on the high sensitivity cardiac biomarker market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Cancer Biomarkers Market: Fact. MR’s extensive coverage on the Cancer biomarkers market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.   

Contact:
Europe Sales Office:
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232 (D)
Tel: +353-1-6111-593 ( Dublin 2 )
 
E: sales@factmr.com
Follow Us: LinkedIn | Twitter
Source: Fact.MR

Back to news